Molecular Mechanism and Approach in Progression of Meningioma

Zhiwei Shao1, Lihong Liu2, Yanghao Zheng3

  • 1Department of Hepatobiliary and Pancreatic Surgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Frontiers in Oncology
|October 12, 2020
PubMed

Insights

Meningiomas, common brain tumors, often recur after surgery. Understanding their chromosomal variations and molecular changes is key to developing targeted therapies for better outcomes.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Genetics

Background:

  • Meningioma is the most common central nervous system tumor, frequently benign but with high recurrence rates even after resection.
  • Understanding meningioma pathogenesis is crucial for developing effective treatments.
  • Chromosomal variations and molecular signals are implicated in meningioma malignancy.

Purpose of the Study:

  • To review advances in chromosomal variations and molecular mechanisms in meningioma progression.
  • To highlight the association between molecular alterations and malignant biological behavior.
  • To discuss current chemotherapy strategies for meningioma.

Main Methods:

  • Literature review of studies on meningioma pathogenesis.
  • Analysis of chromosomal variations and molecular signaling pathways.
  • Summary of chemotherapy efficacy and challenges.

Main Results:

  • Chromosomal variations and abnormal molecular signals correlate with meningioma occurrence and progression.
  • These alterations are linked to increased cell proliferation, angiogenesis, invasiveness, and apoptosis inhibition.
  • Chemotherapy approaches for meningioma are summarized.

Conclusions:

  • Targeted therapies based on identified molecular mechanisms hold promise for meningioma treatment.
  • Further research into meningioma genetics and molecular biology is warranted.
  • Optimizing chemotherapy regimens remains an important clinical goal.